Annual Cash & Cash Equivalents
$14.79 M
-$36.40 M-71.12%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual cash & cash equivalents is $14.79 million, with the most recent change of -$36.40 million (-71.12%) on December 31, 2023.
- During the last 3 years, HEPA annual cash & cash equivalents has fallen by -$25.94 million (-63.69%).
- HEPA annual cash & cash equivalents is now -83.81% below its all-time high of $91.35 million, reached on December 31, 2021.
Performance
HEPA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.50 M
-$617.90 K-29.22%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly cash and cash equivalents is $1.50 million, with the most recent change of -$617.90 thousand (-29.22%) on September 30, 2024.
- Over the past year, HEPA quarterly cash and cash equivalents has dropped by -$17.79 million (-92.24%).
- HEPA quarterly cash and cash equivalents is now -98.70% below its all-time high of $115.45 million, reached on March 31, 2021.
Performance
HEPA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HEPA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.1% | -92.2% |
| 3 y3 years | -63.7% | -98.4% |
| 5 y5 years | +422.0% | -98.4% |
HEPA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.8% | at low | -98.4% | at low |
| 5 y | 5-year | -83.8% | +6.2% | -98.7% | at low |
| alltime | all time | -83.8% | >+9999.0% | -98.7% | >+9999.0% |
Hepion Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.50 M(-29.2%) |
| Jun 2024 | - | $2.12 M(-83.9%) |
| Mar 2024 | - | $13.11 M(-11.4%) |
| Dec 2023 | $14.79 M(-71.1%) | $14.79 M(-23.3%) |
| Sep 2023 | - | $19.28 M(-36.8%) |
| Jun 2023 | - | $30.52 M(-29.0%) |
| Mar 2023 | - | $42.99 M(-16.0%) |
| Dec 2022 | $51.19 M(-44.0%) | $51.19 M(-13.5%) |
| Sep 2022 | - | $59.15 M(-17.5%) |
| Jun 2022 | - | $71.71 M(-9.5%) |
| Mar 2022 | - | $79.22 M(-13.3%) |
| Dec 2021 | $91.35 M(+124.3%) | $91.35 M(-7.5%) |
| Sep 2021 | - | $98.73 M(-10.3%) |
| Jun 2021 | - | $110.09 M(-4.6%) |
| Mar 2021 | - | $115.45 M(+183.5%) |
| Dec 2020 | $40.73 M(+192.5%) | $40.73 M(+197.0%) |
| Sep 2020 | - | $13.71 M(-21.9%) |
| Jun 2020 | - | $17.56 M(+9.4%) |
| Mar 2020 | - | $16.05 M(+15.3%) |
| Dec 2019 | $13.92 M(+391.6%) | $13.92 M(-6.3%) |
| Sep 2019 | - | $14.86 M(-13.3%) |
| Jun 2019 | - | $17.15 M(+919.2%) |
| Mar 2019 | - | $1.68 M(-40.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $2.83 M(-52.4%) | $2.83 M(-68.6%) |
| Sep 2018 | - | $9.03 M(+250.0%) |
| Jun 2018 | - | $2.58 M(-35.5%) |
| Mar 2018 | - | $4.00 M(-54.5%) |
| Dec 2017 | $5.95 M(-54.1%) | - |
| Sep 2017 | - | $8.78 M(-32.4%) |
| Jun 2017 | $12.98 M(+75.3%) | $12.98 M(+111.5%) |
| Mar 2017 | - | $6.14 M(-41.8%) |
| Dec 2016 | - | $10.55 M(+248.4%) |
| Sep 2016 | - | $3.03 M(-59.1%) |
| Jun 2016 | $7.40 M(+62.3%) | $7.40 M(+24.3%) |
| Mar 2016 | - | $5.96 M(-39.4%) |
| Dec 2015 | - | $9.83 M(+449.0%) |
| Sep 2015 | - | $1.79 M(-60.7%) |
| Jun 2015 | $4.56 M(+151.0%) | $4.56 M(-48.7%) |
| Mar 2015 | - | $8.90 M(+1.2%) |
| Dec 2014 | - | $8.79 M(+1095.5%) |
| Sep 2014 | - | $735.40 K(-59.5%) |
| Jun 2014 | $1.82 M(+1996.7%) | $1.82 M(-27.6%) |
| Mar 2014 | - | $2.51 M(>+9900.0%) |
| Dec 2013 | - | $3300.00(-95.7%) |
| Sep 2013 | - | $76.00 K |
| Jun 2013 | $86.70 K | - |
FAQ
- What is Hepion Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Hepion Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Hepion Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of HEPA is $14.79 M
What is the all time high annual cash & cash equivalents for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual cash & cash equivalents is $91.35 M
What is Hepion Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, HEPA annual cash & cash equivalents has changed by -$36.40 M (-71.12%)
What is Hepion Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HEPA is $1.50 M
What is the all time high quarterly cash and cash equivalents for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly cash and cash equivalents is $115.45 M
What is Hepion Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, HEPA quarterly cash and cash equivalents has changed by -$17.79 M (-92.24%)